Abstract

Research Article

Topical Management of chronic rhinosinusitis - A literature review

Aremu Shuaib Kayode* and Tesleem Olayinka Orewole

Published: 26 April, 2019 | Volume 3 - Issue 1 | Pages: 001-006

Chronic rhinosinusitis (CRS) is an inflammatory condition involving nasal passages and the paranasal sinuses for 12 weeks or longer [1]. It can be subdivided into three types: CRS with nasal polyposis (CRS with NP), CRS without nasal polyposis (CRS without NP), and Allergic fungal rhinosinusitis (AFRS). To diagnose CRS we require at least two of four of its cardinal signs/symptoms (nasal obstruction, mucopurulent discharge, facial pain/pressure, and decreased sense of smell). In addition, direct visualization or imaging for objective documentation of mucosal inflammation is required. CRS therapy is aimed to reduce its symptoms and improve quality of life as it cannot be cured in most patients. Thus, the goals of its therapy include the following:

Read Full Article HTML DOI: 10.29328/journal.ated.1001006 Cite this Article Read Full Article PDF

References

  1. Scadding GK, Durham SR, Mirakian R, Jones NS, Leech SC, et al. BSACI guidelines for the management of allergic and non‐allergic rhinitis. Clin Exp Allergy. 2008; 38: 19-42. Ref: https://tinyurl.com/y5wf8f42
  2. Ragab SM, Lund VJ, Scadding G. Evaluation of the medical and surgical treatment of chronic rhinosinusitis: a prospective, randomized, controlled trial. Laryngoscope. 2004; 114: 923-930. Ref: https://tinyurl.com/y4ghtjaz
  3. Head K, Chong LY, Piromchai P, Hopkins C, Philpott C, et al. Systemic and topical antibiotics for chronic rhinosinusitis. Cochrane Database Syst Rev. 2016; 4: CD011994. Ref: https://tinyurl.com/y6eemhdr
  4. Head K, Chong LY, Hopkins C, Philpott C, Burton MJ, et al. Short-course oral steroids alone for chronic rhinosinusitis. Cochrane Database Syst Rev. 2016; 4: CD011991. Ref: https://tinyurl.com/y6ksen3j
  5. Head K, Chong LY, Hopkins C, Philpott C, Schilder AG, et al. Short‐course oral steroids as an adjunct therapy for chronic rhinosinusitis. Cochrane Database Syst Rev. 2016; 4:CD011992. Ref: https://tinyurl.com/yxg2y3k7
  6. Pynnonen MA1, Mukerji SS, Kim HM, Adams ME, Terrell JE. Nasal saline for chronic sinonasal symptoms: a randomized controlled trial. Arch Otolaryngol Head Neck Surg. 2007; 133: 115-1120. Ref: https://tinyurl.com/y38k2ksx
  7. Wormald PJ, Cain T, Oates L, Hawke L, Wong I. A comparative study of three methods of nasal irrigation. Laryngoscope. 2004; 114: 2224-2227. Ref: https://tinyurl.com/y4ky2yd8
  8. Chong LY, Head K, Hopkins C, Philpott C, Glew S, et al. Saline irrigation for chronic rhinosinusitis. Cochrane Database Syst Rev. 2016; 4: CD011995. Ref: https://tinyurl.com/y52qrwz3
  9. Adappa ND, Wei CC, Palmer JN. Nasal irrigation with or without drugs: the evidence. Current opinion in otolaryngology & head and neck surgery. 2012; 20: 53-57. Ref: https://tinyurl.com/y2twptgc
  10. Keen M, Foreman A, Wormald PJ. The clinical significance of nasal irrigation bottle contamination. Laryngoscope. 2010; 120: 2110-2114. Ref: https://tinyurl.com/y2b3e9ax
  11. Chiu AG, Palmer JN, Woodworth BA, Doghramji L, Cohen MB, et al. Baby shampoo nasal irrigations for the symptomatic post-functional endoscopic sinus surgery patient. Am J Rhinol. 2008; 22: 34-37. Ref: https://tinyurl.com/y4lfc2fc
  12. Rosen PL, Palmer JN, O'Malley BW Jr, Cohen NA. Surfactants in the management of rhinopathologies. Am J Rhinol Allergy. 2013; 27: 177-180. Ref: https://tinyurl.com/y5m7pgw6
  13. Hardy JG, Lee SW, Wilson CG. Intranasal drug delivery by spray and drops. J Pharm Pharmacol. 1985; 37: 294-297. Ref: https://tinyurl.com/y3w7r4cs
  14. Aukema AA, Mulder PG, Fokkens WJ. Treatment of nasal polyposis and chronic rhinosinusitis with fluticasone propionate nasal drops reduces the need for sinus surgery. J Allergy Clin Immunol. 2005; 115: 1017-1023. Ref: https://tinyurl.com/y5b7c9do
  15. Harvey RJ, Debnath N, Srubiski A, Bleier B, Schlosser RJ. Fluid residuals and drug exposure in nasal irrigation. Otolaryngol Head Neck Surg. 2009; 141: 757-761. Ref: https://tinyurl.com/y635wosf
  16. Sachanandani NS, Piccirillo JF, Kramper MA, Thawley SE, Vlahiotis A. The effect of nasally administered budesonide respules on adrenal cortex function in patients with chronic rhinosinusitis. Arch Otolaryngol Head Neck Surg. 2009; 135: 303-307. Ref: https://tinyurl.com/y4sd8zvb
  17. Wang C, Lou H, Wang X, Wang Y, Fan E, et al. Effect of budesonide transnasal nebulization in patients with eosinophilic chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2015; 135: 922-929. Ref: https://tinyurl.com/y4l9vbra
  18. Jiang RS, Su MC, Liao CY, Lin JF. Bacteriology of chronic sinusitis in relation to middle meatal secretion. Am J Rhinol. 2006; 20: 173-176. Ref: https://tinyurl.com/y3oc3yfn
  19. Uhliarova B, Karnisova R, Svec M, Calkovska A. Correlation between culture-identified bacteria in the middle nasal meatus and CT score in patients with chronic rhinosinusitis. J Med Microbiol. 2014; 63: 28-33. Ref: https://tinyurl.com/y6oxm2z9
  20. Ikeda K, Ono N, Iizuka T, Kase K, Minekawa A, et al. Bacteriologic Evaluation of Sinus Aspirates Taken by Balloon Catheter Devices in Chronic Rhinosinusitis: Preliminary Study. ORL J Otorhinolaryngol Relat Spec. 2011; 73: 271-274. Ref: https://tinyurl.com/yxftkcw5
  21. Weschta M, Rimek D, Formanek M, Polzehl D, Podbielski A, et al. Topical antifungal treatment of chronic rhinosinusitis with nasal polyps: a randomized, double-blind clinical trial. J Allergy Clin Immunol. 2004; 113: 1122-1128. Ref: https://tinyurl.com/y4a8x27z
  22. Kennedy DW, Kuhn FA, Hamilos DL, Zinreich SJ, Butler D, et al. Treatment of chronic rhinosinusitis with high‐dose oral terbinafine: a double-blind, placebo‐controlled study. Laryngoscope. 2005; 115: 1793-1799. Ref: https://tinyurl.com/y5q5hdzt
  23. Sacks PL, Harvey RJ, Rimmer J, Gallagher RM, Sacks R. Topical and systemic antifungal therapy for the symptomatic treatment of chronic rhinosinusitis. Cochrane Database Syst Rev. 2011; CD008263. Ref: https://tinyurl.com/yy26m8qg
  24. Sacks PL 4th, Harvey RJ, Rimmer J, Gallagher RM, Sacks R. Antifungal therapy in the treatment of chronic rhinosinusitis: a meta-analysis. Am J Rhinol Allergy. 2012; 26: 141-147. Ref: https://tinyurl.com/y25fsguh
  25. Ponikau JU, Sherris DA, Kern EB, Homburger HA, Frigas E, et al. The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc. 1999; 74: 877–884. Ref: https://tinyurl.com/yxv2jzjo
  26. Ponikau JU, Sherris DA, Weaver A, Kita H. Treatment of chronic rhinosinusitis with intranasal amphotericin B: a randomized, placebo-controlled double-blind pilot trial. J Allergy Clin Immunol. 2005; 115: 125–131. Ref: https://tinyurl.com/y2ok8fa2
  27. Ebbens FA, Scadding GK, Badia L. Amphotericin B nasal lavages: not a solution for patients with chronic rhinosinusitis. J Allergy Clin Immunol. 2006; 188: 1149–1156. Ref: https://tinyurl.com/y6odztj4
  28. Kennedy DW, Kuhn FA, Hamilos DL, Zinreich SJ, Butler D, et al. Treatment of chronic rhinosinusitis with high-dose terbinafine: a double-blind, placebo-controlled study. Laryngoscope. 2005; 115: 1793–1799. Ref: https://tinyurl.com/y5q5hdzt
  29. Chan KO, Genoway KA, Javer AR. Effectiveness of itraconazole in the management of refractory allergic fungal rhinosinusitis. J Otolaryngol Head Neck Surg. 2008; 37: 870–874. Ref: https://tinyurl.com/y5647sr4
  30. Rains BM, Mineck CW. Treatment of allergic fungal sinusitis with high-dose itraconazole. Am J Rhinol. 2003; 17: 1–8. Ref: https://tinyurl.com/y5bofn3w
  31. Seiberling K, Wormald PJ. The role of itraconazole in recalcitrant fungal sinusitis. Am J Rhinol Allergy. 2009; 23: 303–306. Ref: https://tinyurl.com/y6ex25qs
  32. Ponikau JU, Sherris DA, Weaver A, Kita H. Treatment of chronic rhinosinusitis with intranasal amphotericin B: A randomized, placebo-controlled, double-blind pilot trial. J Allergy Clin Immunol. 2005; 115: 125–131. Ref: https://tinyurl.com/y2ok8fa2
  33. Liang KL, Su MC, Shiao JY, Tseng HC, Hsin CH, et al. Amphotericin B irrigation for the treatment of chronic rhinosinusitis without nasal polyps: A randomized, placebo-controlled, double-blind study. Am J Rhinol. 2008; 22: 52–58. Ref: https://tinyurl.com/yxpp2mw7
  34. Gerlinger I, Fittler A, Fónai F, Patzkó A, Mayer A, et al. Postoperative application of amphotericin B nasal spray in chronic rhinosinusitis with nasal polyposis, with a review of the antifungal therapy. Eur Arch Otorhinolaryngol. 2009; 266: 847–855. Ref: https://tinyurl.com/y6yx7p55
  35. Weschta M, Rimek D, Formanek M, Polzehl D, Podbielski A, et al. Topical antifungal treatment of chronic rhinosinusitis with nasal polyps: A randomized, double-blind clinical trial. J Allergy Clin Immunol. 2004; 113: 1122–1128. Ref: https://tinyurl.com/y4a8x27z
  36. Hardy JG, Lee SW, Wilson CG. Intranasal drug delivery by spray and drops. J Pharm Pharmacol. 1985; 37: 294-297. Ref: https://tinyurl.com/y3w7r4cs
  37. Daley-Yates PT, Baker RC. Systemic bioavailability of fluticasone propionate administered as nasal drops and aqueous nasal spray formulations. Br J Clin Pharmacol. 2001; 51: 103-105. Ref: https://tinyurl.com/y4ajqdlk
  38. Bryant ML, Brown P, Gurevich N, McDougall IR. Comparison of the clearance of radiolabelled nose drops and nasal spray as a mucosally delivered vaccine. Nucl Med Commun. 1999; 20: 171-174. Ref: https://tinyurl.com/yxt6y6sb

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More